SCHEMBL24110997

SCHEMBL24110997

O=c1c2cc(F)ncc2nc(Nc2cccnc2)n1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.41
KMT2A Q03164 2/20 0.41
RAD52 P43351 1/20 0.41
PDE7A Q13946 1/20 0.39
MAPT P10636 4/20 0.39
MDM2 Q00987 1/20 0.38
PSD A5PKW4 1/20 0.38
LOXL3 P58215 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
MAPK9 P45984 1/20 0.37
USP2 O75604 2/20 0.37
PDE5A O76074 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24111020 0.87 ALOX12 (0.46) ALOX12KMT2ARAD52PDE7AMAPT
SCHEMBL23958265 0.87 PIK3CD (0.46) ALOX12KMT2ARAD52PDE7APDE5A
SCHEMBL29738614 0.87 PIK3CD (0.46) ALOX12KMT2ARAD52PDE7APDE5A
SCHEMBL24111000 0.84 ALOX12 (0.49) ALOX12KMT2ARAD52PDE7AMAPT
SCHEMBL24110995 0.84 ALOX12 (0.57) ALOX12KMT2ARAD52PDE7AMAPT
SCHEMBL24111074 0.84 ALOX12 (0.45) ALOX12KMT2ARAD52PDE7AMAPT
SCHEMBL24110973 0.83 ALOX12 (0.47) ALOX12KMT2ARAD52PDE7AMAPT
SCHEMBL23958278 0.83 TUBB4A (0.45) ALOX12KMT2ARAD52ALDH1A1
SCHEMBL23958245 0.83 PIK3CD (0.50) ALOX12KMT2ARAD52MDM2ALDH1A1
SCHEMBL23958215 0.83 MDM2 (0.49) ALOX12KMT2ARAD52MAPTMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALOX12 3240/4885KMT2A 1451/4885RAD52 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.